| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fece74aa8c0cb73d997c194165159cc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
| filingDate |
2014-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e382238cfc77c6ab46f712375b03654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc6d6aa5e92af3bc163ecfc02fe28b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af2efffb24f7dd8b41a47f175faf4136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662f6f65005db49b37e6503977cae3cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f21862c9c53019be8ac0911c9d6f62c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44985cfe55bb22f17c5d46c11ca0d9ce |
| publicationDate |
2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015051771-A1 |
| titleOfInvention |
A stable pharmaceutical composition containing amlodipine and valsartan |
| abstract |
The present invention relates to a stable pharmaceutical composition having the form of a mono- layer tablet. The composition contains valsartan, amlodipine or pharmaceutically acceptable salts thereof and at least one pharmaceutically acceptable excipient. The pharmaceutical composition in accordance with the invention may contain hydrochlorothiazide as further active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114917226-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108567759-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101875112-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112641743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017007287-A1 |
| priorityDate |
2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |